BridgeMD

Sign in

Sarcoma clinical trials

Explore recruiting sarcoma clinical trials.

Recruiting sarcoma studies right now

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Sarcoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase I Trial of Memory T Cells Expressing an NKG2D Chimeric Antigen Receptor in Children, Adolescents and Young Adults with Advanced Sarcoma

Spain

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Phase 2 Single Arm Open-Label Clinical Trial of ADP-A2M4 SPEAR™ T cells in subjects with Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma (SPEARHEAD 1 STUDY)

France, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase I / II Clinical Trial, multicenter, open, of infusion of activated NK cells for the treatment of children, adolescents and young adults with sarcomas.

Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Phase II Prospective Multicenter Study of High-Dose Treosulfan/Melphalan as Consolidation Treatment in Newly Diagnosed High-Risk and Very High-Risk Ewing Sarcoma.

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

To evaluate the efficacy and safety of naxitamab in patients with refractory Ewing's sarcoma.

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase II Randomized Controlled Trial of Neoadjuvant Pembrolizumab with Radiotherapy and Adjuvant Pembrolizumab in Patients with High-Risk, Localized Soft Tissue Sarcoma of the Extremity

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Sarcoma trials by city

Sarcoma in Toronto Sarcoma in Vancouver Sarcoma in Montreal Sarcoma in Calgary Sarcoma in Edmonton Sarcoma in Ottawa Sarcoma in Winnipeg Sarcoma in Quebec City Sarcoma in Hamilton Sarcoma in Kitchener Sarcoma in London Sarcoma in Halifax Sarcoma in New York Sarcoma in Los Angeles Sarcoma in Chicago Sarcoma in Houston